Validation analysis in datasets from patients with NB confirmed that BIRC5 mRNA was expressed at a significantly higher level in MYCN-amplified tumors (Figure 7D) and strongly predicted patient survival (Figure 7E). Here, MYCN is linked to neuroblastoma.